Arabic Arabic English English French French German German
dark

FDA Grants Breakthrough Device Designation to Wavegate Corporation’s StimuLux

Wavegate Corporation  announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for its StimuLux™ optical reflectometry system for closed-loop adaptive modulation of spinal cord stimulation.  Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

BridgeBio and Amgen Unite on Combination Therapy for Advanced Solid Tumors

Next Post

FDA Approves Novel Treatment to Control Pain in Cats with Osteoarthritis, First Monoclonal Antibody Drug for Use in Any Animal Species

Related Posts
Total
0
Share